| 冒智蕴,徐丹,邱旭升.Charlson指数对多发性骨髓瘤老年病人的预后评估价值[J].安徽医药,2020,24(1):115-118. |
| Charlson指数对多发性骨髓瘤老年病人的预后评估价值 |
| The value of charlson index in the evaluation of prognosis in elderly multiple myeloma |
| |
| DOI：10.3969/j.issn.1009?6469.2020.01.029 |
| 中文关键词: 多发性骨髓瘤 健康状况指标 危险性评估 危险因素 乳酸脱氢酶类 血清白蛋白 Charlson指数 预后 老年人 |
| 英文关键词: Multiple myeloma Health status indicators Risk assessment Risk factors Lactate dehydrogenases Serum albumin Charlson index Prognosis Aged |
| 基金项目:南京市医学科技发展项目( ZKX16034) |
|
| 摘要点击次数: 1992 |
| 全文下载次数: 549 |
| 中文摘要: |
| 目的探讨 Charlson指数在老年多发性骨髓瘤病人预后的评估价值。方法选择 2015年 1月至 2018年 1月如皋市人民医院收治的老年多发性骨髓瘤 84例作为研究对象，对所有病人临床资料进行回顾性分析。所有病人根据 Charlson指数评分标准分为 A组( ≥5分) 22例、 B组(＜ 5分) 62例，对两组病人临床特征、实验室指标进行单因素、多因素分析，并对比两组生存时间。结果 Charlson指数评分 ≥5分、年龄 ≥75岁、 ISS分期 Ⅲ期、血清肌酐( SCr)≥176.8 μmol/L、血红蛋白( Hb)＜100 g/L、乳酸脱氢酶( LDH)＞245 U/L是影响老年多发性骨髓瘤病人预后的危险因素( P＝0.000，0.026，0.014，0.014，0.035，0.000)； Charlson指数评分 ≥5分、 LDH＞245 U/L是影响老年多发性骨髓瘤病人预后的独立危险因素(均 P＜0.001)； B组中位生存期为 46个月，长于 A组的 26个月( P＜0.001)。结论 Charlson指数应用于评估老年多发性骨髓瘤病人预后效果具有显著临床价值，值得推广。 |
| 英文摘要: |
| Objective To investigate the value of Charlson index in the evaluation of prognosis of elderly patients with multiple my? eloma.Methods Eighty?four patients with multiple myeloma admitted to Rugao people’s Hospital from January 2015 to January2018 were selected as the study subjects.All patients were retrospectively analyzed.All patients were divided into group A(≥5 points)22 cases and group B(＜ 5 points)62 cases according to the Charlson index scoring standard.The clinical characteristicsand laboratory parameters of the two groups were analyzed by univariate and multivariate analysis.The group survival time werecompared.Results Charlson’s index score≥5，age≥75，ISS stage Ⅲ，serum creatinine(SCR)≥176.8 μmmol/L，hemoglobin(HB)＜ 100 g/L，lactate dehydrogenase(LDH)＞245 U/L were risk factors affecting the prognosis of patients with multiple myeloma(P＝ 0.000，0.026，0.014，0.014，0.035，0.000).Charlson index score≥5 points，LDH＞245 U/L is an independent risk factor affecting the prognosis of patients with multiple myeloma in the elderly(all P＜0.001).The median survival time of group B was 46 months， which was longer than 26 months of group A，and the difference was statistically significant(P＜0.001).Conclusion The Charl? son index has significant clinical value in evaluating the prognosis of patients with multiple myeloma in the elderly，which worthy of promotion. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
